Form 8-K - Current report:
SEC Accession No. 0001193125-24-089300
Filing Date
2024-04-08
Accepted
2024-04-08 11:06:59
Documents
15
Period of Report
2024-04-08
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d805028d8k.htm   iXBRL 8-K 50559
2 EX-3.1 d805028dex31.htm EX-3.1 9769
3 EX-3.2 d805028dex32.htm EX-3.2 64853
  Complete submission text file 0001193125-24-089300.txt   279645

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sctl-20240408.xsd EX-101.SCH 2864
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sctl-20240408_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sctl-20240408_pre.xml EX-101.PRE 11716
18 EXTRACTED XBRL INSTANCE DOCUMENT d805028d8k_htm.xml XML 3822
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Societal CDMO, Inc. (Filer) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 24828552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)